"Designing Growth Strategies is in our DNA"

Brain Implants Market Size, Share & Industry Analysis, By Product (Deep Brain Stimulation, Vagus Nerve Stimulation, and Responsive Neurostimulation), By Application (Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Schizophrenia, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI105021

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 11.1% from 2025-2032

Unit

Value (USD billion)

Segmentation

By Product

  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Responsive Neurostimulation

By Application

  • Epilepsy
  • Parkinson's Disease 
  • Alzheimer's Disease
  • Schizophrenia
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product, By Application, By End-user, By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Application, By End-user, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, By Application, By End-user, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Rest of the World (By Product, By Application, By End-user)

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 180
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann